نتایج جستجو برای: ipratropium bromide

تعداد نتایج: 17504  

Journal: :Chest 1983
E McIntyre J H Alpers R E Ruffin

2004
RG TAYLOR D PAVIA JE AGNEW MT LOPEZ-VIDRIERO

In a randomised, double blind crossover study the effect of high dose ipratropium bromide (200 pg three times daily given by metered dose inhaler for four weeks) on lung mucociliary clearance and on the wet weight and mean apparent viscosity of sputum was compared with that of placebo. Six smokers, six ex-smokers, and three non-smokers (12 men and three women, median age 60 years) were studied....

Journal: :Thorax 1982
J A Hughes M J Tobin D Bellamy D C Hutchison

In patients with radiological evidence of pulmonary emphysema the bronchodilator drugs fenoterol and ipratropium bromide produced a considerable increase in vital capacity and reduction in residual volume. The response to fenoterol was virtually complete 15 minutes after administration, but after ipratropium bromide vital capacity was still increasing at 60 minutes. The change in vital capacity...

Journal: :Journal of postgraduate medicine 2006
S S Qureshi S Navadgi T Shet Rajesh C Mistry

Ipratropium bromide (Atrovent) is a commonly and widely used antimuscarinic bronchodilator with very few side-effects. Although buccal ulceration and haemorrhagic bullae affecting the palate have been reported with ipratropium bromide (IB) they do not appear in the British National Formulary and are not mentioned in the manufacturer’s (Atrovent) product information either. Therefore, we believe...

Journal: :Thorax 1990
G Nichol A Nix P J Barnes K F Chung

The effect of inhaled prostaglandin (PG) F2 alpha on the response to the inhaled tussive agent capsaicin was investigated in normal subjects. Seven subjects inhaled three breaths of four doses of capsaicin (0.3, 0.6, 1.2, and 2.4 nmol) before and immediately after inhaling PGF2 alpha (0.1 mumol) or placebo (0.15M NaCl) on separate days. The numbers of capsaicin induced coughs were greater after...

Journal: :Chest 2010
Sarika S Ogale Todd A Lee David H Au Denise M Boudreau Sean D Sullivan

BACKGROUND Studies have suggested an increased risk of cardiovascular morbidity and mortality associated with the use of ipratropium bromide. We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs). METHODS We performed a cohort study of 82,717 US veterans with a new diagnosis of COPD between 1999 and 2002. Subjects were followed until...

Journal: :Thorax 1996
P I Field R Simmul S C Bell D H Allen N Berend

BACKGROUND Inhalation of sulphur dioxide (SO2) provokes bronchoconstriction in asthmatic subjects. Cholinergic mechanisms contribute, but other mechanisms remain undefined. The effect of morphine, an opioid agonist, on the cholinergic component of SO2-induced bronchoconstriction was investigated, and the effect of indomethacin, a cyclooxygenase inhibitor, on SO2-induced bronchoconstriction and ...

Journal: :Thorax 1980
J P Hartley B H Davies

The contribution of vagal mechanisms to exercise-induced asthma has been studied in 10 adult asthmatic patients using the anticholinergic drug ipratropium bromide. Exercise tests were performed for eight minutes on a cycle ergometer and each individual's tests were standardised by matching oxygen uptake. Two tests were done on each of three study days, the first being without previous medicatio...

Journal: :Chest 1990
A R Glanville J Theodore J C Baldwin E D Robin

We evaluated bronchial responsiveness to inhaled albuterol (salbutamol), ipratropium bromide, methacholine, and propranolol in eight heart-lung transplant (HLT) recipients 2.3 +/- 1.5 months (mean +/- SD) (range, 1 to 4.5 months) after HLT. All patients had a restrictive ventilatory defect but none had airflow limitation (FEV1/FVC = 0.93 +/- 0.05) (range, 0.86 to 0.97). Specific airway conducta...

Journal: :American journal of physiology. Lung cellular and molecular physiology 2012
Ken-Ichiro Tanaka Keizo Sato Kazutetsu Aoshiba Arata Azuma Tohru Mizushima

Bronchodilators (such as ipratropium bromide), steroids (such as fluticasone propionate), and newly developed anti-inflammatory drugs (such as roflumilast) are used for patients with chronic obstructive pulmonary disease (COPD). We recently reported that lecithinized superoxide dismutase (PC-SOD) confers a protective effect in mouse models of COPD. We here examined the therapeutic effect of the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید